All Industry news articles – Page 6
-
Industry newsMHRA Corporate Plan supports access for patients to innovation
The MHRA’s Corporate Plan for 2023-26 seeks to set out how it will enable access to innovative medical products while ensuring patient safety.
-
Industry newsWellcome grants £5.7 million to combat MRSA
The Wellcome Trust’s Discovery Award has granted £5.7 million to a University of Sheffield team for research into antibiotic resistance.
-
Industry newsWearables can spot Parkinson’s up to seven years earlier
A smartwatch has been shown to be able to identify Parkinson’s disease up to seven years before symptoms appeared shows Cardiff University study.
-
Industry newsAI brings control of gene expression to CRISPR tech
CRISPR, the precision gene-editing technology, has been combined with artificial intelligence to control gene expression.
-
Industry newsAustralia moves to permit therapeutic use of psychedelics
The Therapeutic Goods Administration − Australia’s regulator − approves MDMA and psilocybin for treatment of PTSD and depression.
-
Industry newsAI-generated drug first to reach Phase II trials
Insilico Biotech’s INS018_055 – a drug generated by AI – is a treatment for a rare lung disease and the first AI drug to enter a Phase II trial.
-
Industry newsStakeholder feedback sought on EMA draft clinical guidelines
The EMA has published draft guidance − ICH E6 (R3) − on good clinical practice for clinical trials, which is open for public consultation.
-
Industry newsTwo paediatric type 2 diabetes oral drugs receive FDA approval
FDA approves Jardiance and Synjardy as treatments to improve the control of blood sugar in children aged 10 years and older, with type 2 diabetes.
-
Industry newsFDA issues guidance for clinical trials of psychedelic drugs
The FDA has released guidance to researchers on how to test psychedelic drugs; seeks the public’s input as to other potential uses.
-
Industry newsNHS to receive £21 million fund for AI diagnostics
NHS Trusts will be able to apply to a dedicated AI diagnostics fund which totals £21 million, the Secretary of State for Health and Social Care announced.
-
Industry newsDisposable vapes: FDA cracks down on illegal sales
The FDA operates a ‘red list’ mechanism which means that products listed there can be banned without physical examination.
-
Industry newsUK and Ireland VetMed product label guidance
Ireland’s HPRA and the UK’s VMD have produced interim guidance clarifying the joint labels for veterinary medicines authorised in the two countries.
-
Industry newsUmbrella EU-US VetMed MRA comes one step closer
EU and US make progress towards a mutual recognition agreement for manufacturing inspections of veterinary products.
-
Industry newsAI-enabled imaging cuts serious stroke diagnosis times
Med-Tech Innovation Conference keynote ‘fireside chat’: Dr Paul Bhogal, Royal London Hospital and Gianluca Casali, Johnson & Johnson.
-
Industry newsNeuralink gets FDA approval for its first brain device trials
Elon Musk’s Neuralink receives FDA approval to conduct a first clinical trial in humans of its experimental brain-computer interface ‘The Link’.
-
Industry newsNICE recommends its first-ever oral migraine treatment
Rimegapant – has been approved for use in the NHS giving a treatment option for people who have failed with different drug options.
-
Industry newsMHRA plans medical device technologies streamlined pathway
UK agency aims to make route-to-market much more straightforward for manufacturers with Innovative Devices Access Pathway.
-
Industry newsMHRA seals deal for fast international recognition routes
UK agency adopts recognition routes from seven national authorities; new signals start of new international framework for medicines.
-
Industry newsIllegal vapes found to contain lead and nickel: TOPRA Fellow
Inter Scientific - founded by TOPRA Fellow David Lawson - tests vapes confiscated from school children as part of BBC News investigation.
-
Industry newsGene therapy gives hope to patients with ‘butterfly skin’
FDA approves first gene therapy to treat dystrophic epidermolysis
bullosa patients – a condition sometimes called ‘butterfly skin’.